Did you know?

GHP integrates structural and process elements of the organisation, the professional groups, the specialist disciplines and the services that the hospital uses to fulfil its task.

Start now
Updated on 4 February 2025

5.2.07 Risk assessment for clinical studies

Estimated reading: 1 minute 974 views Authors Avatar photo

Goal and purpose

A process-related matrix of risks and risk assessments (risk indicators) with corresponding measures to reduce risks is created for all phases of a research project. The acceptability of residual risks is assessed. The acceptability of the residual risks is assessed. For the method, see 5.4.05

Application

Description of the process

Risks

Resources

Material

Time required

Documentation

Responsibility and qualification

Notes and comments

Applicable documents

Validation documents

Terms

Attachments

5.2 Analysis and validation - Previous 5.2.06 Planning and conducting clinical trials (Clinical Trial Manual) Next - 5.2 Analysis and validation 5.2.08 Creation of a risk matrix for treatment patterns

Leave a Comment

Edit manual
Share this document

5.2.07 Risk assessment for clinical studies

Or copy link

CONTENTS

Comment

en_GB
de_DE fr_FR es_ES en_GB

Subscribe

×
Cancel